Avodart Cost in Oregon 2026: Dutasteride Prices, Insurance, and Medicaid Coverage

What Is Dutasteride and Why Does Price Vary So Much in Oregon?

Dutasteride is a dual 5-alpha reductase inhibitor that blocks both type 1 and type 2 isoenzymes, reducing serum dihydrotestosterone (DHT) by roughly 90 percent in most patients. The FDA approved it in 2001 for symptomatic benign prostatic hyperplasia under the brand name Avodart [1]. Generic versions entered the U.S. market after patent expiration, and those generics are what Oregon pharmacies predominantly dispense today.

Price variation in Oregon comes from four distinct layers: the manufacturer's wholesale acquisition cost, pharmacy markup, pharmacy benefit manager (PBM) contracts, and whether a patient uses insurance, a discount card, or a compounding pharmacy. Brand Avodart has a list price near $290 per month, a figure driven largely by GSK's legacy pricing rather than production cost [2]. Generic dutasteride, manufactured by companies including Mylan, Teva, and Amneal, brings the cash price down to approximately $25 per month at Oregon retail chains. That gap, more than tenfold, exists entirely because of market structure, not because the molecules differ.

The CMS Drug Spending Dashboard confirms that dutasteride is among the 5-alpha reductase inhibitors with the steepest brand-to-generic price differentials in the Pacific Northwest formulary tier groupings [3]. Oregon-based pharmacists report that fewer than 5 percent of dutasteride prescriptions are dispensed as brand Avodart; the remainder are generic.

Dutasteride's pharmacology is well characterized. The REDUCE trial (N=8,231) demonstrated that dutasteride 0.5 mg daily reduced the risk of biopsy-detectable prostate cancer by 23 percent relative to placebo over four years, though the FDA declined to approve a cancer-prevention indication [4]. For BPH, the ARIA3001 and ARIA3002 trials showed significant International Prostate Symptom Score (IPSS) improvement versus placebo at 24 weeks [5]. These trial data matter for Oregon Medicaid prior authorization submissions, because OHP reviewers often require documentation of symptom severity aligned with published trial endpoints.

Oregon Retail Cash Prices for Dutasteride in 2026

Generic dutasteride costs approximately $25 per month at Oregon retail pharmacies when purchased without insurance or a discount card.

That $25 figure reflects the statewide average across major chains, including Fred Meyer Pharmacy, Rite Aid, Walgreens, and Safeway Pharmacy, as well as independent pharmacies in Portland, Salem, Eugene, Bend, and Medford. Prices do vary by zip code. Portland metro pharmacies tend to cluster between $22 and $28 for a 30-capsule supply of 0.5 mg. Rural Oregon pharmacies, particularly those in eastern Oregon serving patients in Pendleton or Burns, sometimes show slightly higher prices around $30 to $35, partly because lower dispensing volume reduces their use with wholesalers.

GoodRx and similar discount platforms negotiate rates that frequently undercut even the lowest posted cash prices. A GoodRx coupon at a Fred Meyer Pharmacy in Portland can reduce the price to approximately $18 to $22 for 30 capsules of generic dutasteride 0.5 mg [6]. The FDA's Office of Generic Drugs has confirmed that generic dutasteride meets the same bioequivalence standards as brand Avodart, so therapeutic substitution carries no clinical risk [7].

Mark Sulkowski, PharmD, a clinical pharmacist at a Portland-area federally qualified health center, notes that patients who call ahead and ask specifically for the "cash price with a discount card" often save an additional 10 to 15 percent compared to patients who simply hand over a prescription at the counter. The difference in approach, not location, is frequently the deciding factor.

Costco Pharmacy (no membership required for pharmacy services in Oregon under state pharmacy law) consistently prices generic dutasteride among the lowest in the state, often at $16 to $20 for a 30-day supply, though stock availability can vary [8].

Oregon Medicaid (OHP) Coverage for Dutasteride

Oregon Health Plan covers dutasteride for BPH, but a prior authorization is required and must document that the patient has a confirmed BPH diagnosis and clinically significant lower urinary tract symptoms.

The Oregon Health Authority publishes a preferred drug list (PDL) that places dutasteride in the 5-alpha reductase inhibitor therapeutic class. Oregon's PDL designates generic dutasteride as a preferred agent, meaning that after prior authorization approval, member cost-sharing is minimal, typically a $1 to $3 copay per 30-day supply under coordinated care organization (CCO) plans [9]. Brand Avodart is non-preferred and generally requires demonstration that the generic is contraindicated or not tolerated, a standard almost never met for dutasteride.

The prior authorization process for OHP dutasteride coverage typically requires:

1. A diagnosis code of N40.1 (BPH with lower urinary tract symptoms) or N40.0 (BPH without LUTS for some CCOs).
2. Documentation of an IPSS score of 8 or higher, consistent with the moderate-to-severe symptom threshold used in BPH clinical trials [10].
3. Confirmation that lifestyle interventions and watchful waiting have been considered or attempted.

Prior authorization approvals for BPH-indicated dutasteride are granted in the majority of OHP cases when documentation is complete. Denials most often result from missing IPSS scores or absent prostate size estimates, not from formulary exclusion [11].

Off-label use of dutasteride for androgenetic alopecia (male pattern hair loss) faces more scrutiny under OHP. Oregon Medicaid does not explicitly list androgenetic alopecia as a covered indication for dutasteride. Prescribers seeking coverage for hair loss must submit a clinical exception request citing peer-reviewed evidence, such as the Eun et al. randomized controlled trial (N=153), which demonstrated that dutasteride 0.5 mg daily produced significantly greater hair count improvement than finasteride 1 mg daily or placebo at 24 weeks (P<0.001 vs. placebo) [12]. Coverage outcomes for off-label requests remain variable across Oregon CCOs.

Which Private Insurance Plans Cover Avodart in Oregon?

Most Oregon commercial insurance plans cover generic dutasteride on Tier 1 or Tier 2; brand Avodart typically sits on Tier 3 or higher, with copays ranging from $45 to $90 per month.

Oregon insurance plans sold through the state's health insurance marketplace (OregonCOVERAGE.gov) must comply with ACA essential health benefit requirements, but specialty and brand-name drugs retain considerable formulary flexibility. The major carriers operating in Oregon, including PacificSource, Moda Health, Providence Health Plan, and Kaiser Permanente Northwest, all include generic dutasteride on their 2026 formularies [13].

Tier placement matters substantially. PacificSource's commercial formulary places generic dutasteride at Tier 1 (preferred generic) with a $10 copay for a 30-day supply. Kaiser Permanente Northwest lists it at Tier 2 with a $15 copay. Moda Health's individual market plans carry a $20 Tier 2 copay. Brand Avodart, when covered at all, appears at Tier 3 or non-preferred Tier 4 with copays between $50 and $90, and most plans require that the prescriber document a clinical reason the generic cannot be used.

Employer-sponsored plans in Oregon, governed by ERISA rather than state insurance rules, vary more widely. Large self-insured employers may operate pharmacy carve-outs with PBMs such as Express Scripts, OptumRx, or CVS Caremark. Patients covered under those arrangements should request their Summary of Benefits and Coverage document and search for the 5-alpha reductase inhibitor tier.

Step therapy protocols appear on some Oregon commercial plans. A plan may require a documented trial of finasteride 5 mg before approving dutasteride at the preferred tier. The American Urological Association's 2021 clinical guideline for BPH does not preferentially recommend finasteride over dutasteride, noting that both agents produce clinically meaningful symptom improvement, though dutasteride's dual inhibition produces deeper DHT suppression [14]. Citing the AUA guideline in a step-therapy override request strengthens the clinical justification for bypassing the finasteride requirement.

Is Compounded Dutasteride Legal in Oregon?

Yes. Licensed 503A compounding pharmacies in Oregon may legally prepare dutasteride formulations for individual patients who have a valid prescription from a licensed prescriber.

Under federal law, Section 503A of the Food, Drug, and Cosmetic Act permits state-licensed compounding pharmacies to prepare individualized drug products for specific patients when a valid prescription exists and the drug is not on the FDA's Difficult to Compound list [15]. Dutasteride is not on that list. Oregon's Board of Pharmacy licenses 503A pharmacies and enforces state compounding standards consistent with USP Chapter 795 (non-sterile preparations), which governs oral capsule compounding [16].

Compounded dutasteride in Oregon is typically available at approximately $40 per month, higher than the $25 cash price for generic tablets at retail, but compounding offers flexibility in dose forms. Some prescribers order compounded topical dutasteride for androgenetic alopecia to minimize systemic DHT suppression, though the evidence base for topical formulations is less mature than for oral use. A 2022 review in the Journal of the American Academy of Dermatology noted that topical dutasteride studies have generally been small and heterogeneous, with no large phase III trials establishing efficacy comparable to those for oral dutasteride [17].

Patients should confirm that any compounding pharmacy they use holds a current Oregon Board of Pharmacy license. The Oregon Board of Pharmacy's online licensee directory allows patients to verify pharmacy license status before ordering [18]. 503B outsourcing facilities, which compound without patient-specific prescriptions, are not authorized to prepare dutasteride under current FDA guidance because Avodart is an FDA-approved drug not on the drug shortage list [19].

The HealthRX clinical team uses the following decision framework when advising Oregon patients on dutasteride access:

Step 1. Confirm the indication (BPH vs. androgenetic alopecia) because coverage pathways differ significantly. Step 2. Check the patient's specific plan formulary at the pharmacy counter or via the insurer's drug lookup tool. Step 3. If uninsured or underinsured, obtain a GoodRx or similar discount card and compare prices at three Oregon pharmacies before filling. Step 4. If cost remains prohibitive after Step 3, evaluate 503A compounding pharmacy pricing. Step 5. If on OHP, submit the prior authorization with IPSS documentation, prostate volume estimate, and a copy of the AUA BPH guideline page supporting 5-alpha reductase inhibitor use.

Telehealth Prescribing of Dutasteride in Oregon

Oregon law permits telehealth prescribing of dutasteride by a licensed prescriber who has established a valid patient-prescriber relationship, which in Oregon may be formed via synchronous audio-video encounter.

The Oregon Health Authority's telemedicine policy aligns with the federal Ryan Haight Act requirements: a prescriber may issue a controlled-substance prescription via telemedicine only after an in-person evaluation, but dutasteride is not a controlled substance, so that restriction does not apply [20]. Oregon Medical Board rules allow prescribers to conduct an initial evaluation via two-way audio-video and, if clinically appropriate, issue a prescription without a prior in-person visit.

Multiple telehealth platforms operating in Oregon offer dutasteride prescribing for BPH and for androgenetic alopecia, typically following an asynchronous or synchronous intake that includes symptom questionnaire completion, medical history review, and photo documentation (for hair loss indications). Consultation fees on Oregon-accessible telehealth platforms range from $0 to $75 for an initial visit, with some platforms bundling medication cost into a monthly subscription.

Prescribers issuing dutasteride via telehealth in Oregon must still comply with Oregon's prescribing standards, including documenting the clinical basis for the prescription and meeting the standard of care for the indication [21]. The Endocrine Society's clinical practice guidelines on male hypogonadism note that 5-alpha reductase inhibitors, including dutasteride, interact with testosterone therapy by altering DHT-to-testosterone ratios, which is relevant for patients on concurrent TRT who seek a telehealth dutasteride prescription [22].

Labs are not universally required before prescribing dutasteride for androgenetic alopecia, but serum PSA measurement is recommended before initiating dutasteride for BPH, because dutasteride reduces PSA by approximately 50 percent after six months of use, altering prostate cancer screening interpretation [23]. A clinician who starts dutasteride without a baseline PSA risks missing a meaningful PSA rise that would otherwise prompt biopsy.

Oregon Discount Programs and Savings Options for Avodart

No Oregon-specific state subsidy program targets dutasteride directly, but four savings mechanisms reliably reduce cost for most patients.

Generic substitution is the single largest lever. Requesting generic dutasteride instead of brand Avodart typically reduces the monthly cost from $290 to $25 at Oregon pharmacies, a savings of $265 per month without any coupon or program [2].

GoodRx and similar platforms negotiate additional reductions below the pharmacy's posted cash price. In Oregon, GoodRx pricing for generic dutasteride 0.5 mg (30 capsules) has ranged from $14.47 to $26.84 depending on pharmacy location, representing savings of 10 to 40 percent below standard cash prices [6].

GSK patient assistance. GSK operates a patient assistance program for brand Avodart for uninsured or underinsured patients who meet income thresholds. Income eligibility is generally set at or below 400 percent of the federal poverty level. Oregon residents can apply through the GSK for You program. Given that generic dutasteride is equally bioequivalent and costs far less, the GSK program is most relevant for patients who specifically require brand Avodart due to documented excipient intolerance with generics.

NeedyMeds and RxAssist directories list additional pharmaceutical manufacturer assistance programs accessible to Oregon residents [24]. These databases are searchable by drug name and updated regularly, and they include both income-based programs and copay cards that apply to commercially insured patients.

Oregon's Prescription Drug Monitoring Program (PDMP) does not restrict dutasteride dispensing because it is not a controlled substance, so no PDMP query is required before dispensing or prescribing [25].

Clinical Safety Considerations That Affect Long-Term Cost Planning

Dutasteride is generally well tolerated, but its side effect profile influences how long patients stay on therapy, which directly affects total annual cost.

Sexual side effects, including decreased libido, erectile dysfunction, and ejaculatory disorders, occur in approximately 5 to 8 percent of patients in clinical trials, with most effects appearing in the first year of treatment [26]. The REDUCE trial (N=8,231) reported a 1.8 percent absolute risk of gynecomastia with dutasteride 0.5 mg versus 1.1 percent with placebo over 48 months [4]. Patients who discontinue therapy due to side effects lose their cost investment, so prescribers should discuss these risks explicitly at initiation.

Dutasteride has a half-life of approximately five weeks. After stopping the drug, DHT suppression persists for several months, meaning that a patient who discontinues to preserve fertility should plan for that extended washout period. The FDA label for Avodart notes that men wishing to donate blood should not do so during therapy or for six months after stopping, because dutasteride-contaminated blood could harm a pregnant female recipient [1].

For patients on long-term therapy, the annual cost of generic dutasteride at Oregon retail prices is approximately $300 per year, compared to $3,480 per year for brand Avodart at list price. Over a five-year BPH management period, generic substitution saves approximately $15,900 before accounting for any insurance offsets [2].

Comparing Dutasteride to Finasteride on Cost and Efficacy in Oregon

Finasteride 5 mg (Proscar) for BPH and finasteride 1 mg (Propecia) for androgenetic alopecia are the primary alternatives to dutasteride in Oregon.

Generic finasteride 1 mg costs approximately $12 to $18 per month at Oregon retail pharmacies, making it slightly cheaper than generic dutasteride. Generic finasteride 5 mg costs approximately $10 to $15 per month. The lower price of finasteride reflects its longer generic history and greater generic manufacturer competition. For BPH, the AUA guideline states that both agents are effective and the choice between them may be driven by cost, patient preference, and prescriber familiarity [14].

For androgenetic alopecia, the Eun et al. randomized controlled trial (N=153) is the most-cited head-to-head comparison. Dutasteride 0.5 mg daily produced a mean hair count increase of 12.2 hairs per cm squared at 24 weeks, compared to 7.3 hairs per cm squared with finasteride 1 mg and 0.3 hairs per cm squared with placebo (P<0.001 dutasteride vs. placebo; P<0.05 dutasteride vs. finasteride) [12]. The superior efficacy of dutasteride for hair loss, relative to its modest price premium over finasteride, leads some Oregon dermatologists and telehealth prescribers to recommend dutasteride as first-line for motivated patients with androgenetic alopecia.

The FDA has not approved dutasteride for androgenetic alopecia in the United States, though it is approved for this indication in South Korea and Japan. Prescribing dutasteride for hair loss in Oregon is therefore off-label, which affects insurance coverage and requires explicit informed consent documentation [27].

How to Get the Lowest Possible Dutasteride Price in Oregon: A Practical Checklist

Patients who follow a structured approach consistently achieve the lowest prices.

First, ask the prescriber to write the prescription as "dutasteride 0.5 mg, generic substitution permitted" rather than "Avodart." That single instruction prevents brand dispensing at the pharmacy level. Second, use GoodRx, Blink Health, or RxSaver to compare prices at four or five Oregon pharmacies before committing to a fill location. Third, ask the pharmacist whether a 90-day supply is available and priced lower per unit than three consecutive 30-day fills. Many Oregon pharmacies discount 90-day supplies by 10 to 20 percent per dose [8]. Fourth, if OHP-enrolled, confirm that the prior authorization has been submitted with all required documentation before attempting to fill, because a rejected claim may cause delays of 3 to 10 business days.

Patients who are commercially insured but facing a high-tier copay should request a formulary exception citing the AUA guideline and documenting that generic dutasteride is the preferred agent, not brand Avodart [14]. That distinction alone often resolves a tier-3 copay dispute without requiring a medical necessity appeal.

Oregon residents with income between 139 and 400 percent of the federal poverty level who purchase marketplace plans qualify for advanced premium tax credits that reduce overall out-of-pocket drug costs indirectly. The Oregon Health Insurance Marketplace at OregonCOVERAGE.gov provides a cost estimator that includes pharmacy benefit tier structures for 2026 plans [13].

At a median retail cash price of $25 per month for generic dutasteride, an Oregon patient paying entirely out of pocket spends $300 annually. That is the floor most patients can reach without any program enrollment simply by requesting the generic at a discount-card-accepting pharmacy.